The OS rate of patients with bladder cancer with higher IGF2BP3 expression in tumours was significantly poorer than that of patients with lower IGF2BP3 expression in tumours (P = 0.0277, Figure 1G). This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.